TrialDiabetes/metabolism research and reviews2015

A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.

Chang Hee Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.